Skip to main content

Foghorn Therapeutics Inc.

FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822462

No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Foghorn Therapeutics Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of FHTX: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders5969+10
Shares26.2M26.5M+265.7K (+1.0%)
Value$169.0M$177.4M+$8.49M (+5.0%)

New holders (12)

Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to FHTX in Q1 2024
InstitutionSharesValue% of portfolio
Colony Group, LLC107,770$632.0K0.01%
Millennium Management LLC62,047$416.3K0.00%
Invesco Ltd.56,042$376.0K0.00%
Acadian Asset Management LLC42,367$283.0K0.00%
Marshall Wace, LLP36,526$245.1K0.00%
Citadel Advisors LLC23,973$160.9K0.00%
XTX Topco Ltd13,448$90.2K0.01%
State Board of Administration of Florida Retirement System12,474$77.3K0.00%
Simplex Trading, LLC2,119$14.0K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC3$200.00%
CWM, LLC1$00.00%
Capital Advisors, Ltd. LLC7$00.00%

Sold out (2)

Institutions that held Foghorn Therapeutics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of FHTX in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Jane Street Group, LLC12,851$82.9K
Russell Investments Group, Ltd.100$645